These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 9615734
21. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat. Luo S, Sourla A, Labrie C, Bélanger A, Labrie F. Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961 [Abstract] [Full Text] [Related]
22. A comparison of the efficacy for antitumor activity of the non-steroidal antiestrogens analog II and tamoxifen in 7,12-dimethylbenz[a] anthracene-induced rat mammary tumors. Pento JT, Magarian RA, King MM. Cancer Lett; 1982 Oct; 15(3):261-9. PubMed ID: 6811128 [No Abstract] [Full Text] [Related]
23. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma. Zanardi S, De Menech R, Pino G, Guarneri D, Dandolo G, Sanguineti M, Moro MG, Barbi GP, Paganuzzi M, Boccardo F. Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642 [Abstract] [Full Text] [Related]
30. [One year observation on effects of estrogen, tamoxifen combined with or without fluoride on preventing bone loss in ovariectomized rats]. Liu H, Peng H, Liu J. Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):82-5. PubMed ID: 11953070 [Abstract] [Full Text] [Related]
31. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model. Cohen LA, Pittman B, Wang CX, Aliaga C, Yu L, Moyer JD. Cancer Res; 2001 Dec 15; 61(24):8683-8. PubMed ID: 11751385 [Abstract] [Full Text] [Related]
32. Effect of tamoxifen on bone mineral density and blood lipids in ovariectomized rats. Czerny B, Pawlik A, Juzyszyn Z, Myśliwiec Z. Pol J Pharmacol; 2003 Dec 15; 55(6):1137-42. PubMed ID: 14730112 [Abstract] [Full Text] [Related]
33. Laboratory models of breast cancer to aid the elucidation of antiestrogen action. Jordan VC. J Lab Clin Med; 1987 Mar 15; 109(3):267-77. PubMed ID: 3102656 [Abstract] [Full Text] [Related]
34. [Ultrastructural study of rat mammary tumors and human breast cancer cells following treatment with tamoxifen]. Kamioki S. Gan No Rinsho; 1986 Nov 15; 32(14):1809-18. PubMed ID: 3099030 [Abstract] [Full Text] [Related]
38. [Cumulative effects of lentinan and endocrine therapy on the growth of DMBA-induced mammary tumor in rats]. Kosaka A, Imaizumi A, Hatori Y, Mori F, Wani T, Yamashita A. Gan To Kagaku Ryoho; 1984 Jul 15; 11(7):1399-407. PubMed ID: 6430243 [Abstract] [Full Text] [Related]
39. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system. Rorke EA, Katzenellenbogen BS. Cancer Res; 1981 Apr 15; 41(4):1257-62. PubMed ID: 6783294 [No Abstract] [Full Text] [Related]
40. CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo. Schieweck K, Bhatnagar AS, Matter A. Cancer Res; 1988 Feb 15; 48(4):834-8. PubMed ID: 2962734 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]